Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

2.

Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study.

Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Machulda M, Lowe VJ, Mielke MM, Roberts RO, Gunter JL, Senjem ML, Geda YE, Rocca WA, Petersen RC, Jack CR Jr.

Neurology. 2016 Mar 22;86(12):1128-35. doi: 10.1212/WNL.0000000000002490. Epub 2016 Feb 24.

3.

Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.

Podhorna J, Krahnke T, Shear M, Harrison JE; Alzheimer’s Disease Neuroimaging Initiative..

Alzheimers Res Ther. 2016 Feb 12;8:8. doi: 10.1186/s13195-016-0170-5.

4.

Cognitive stimulation of the default-mode network modulates functional connectivity in healthy aging.

De Marco M, Meneghello F, Duzzi D, Rigon J, Pilosio C, Venneri A.

Brain Res Bull. 2016 Mar;121:26-41. doi: 10.1016/j.brainresbull.2015.12.001. Epub 2015 Dec 11.

PMID:
26688237
5.

Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.

Hochstetler H, Trzepacz PT, Wang S, Yu P, Case M, Henley DB, Degenhardt E, Leoutsakos JM, Lyketsos CG.

J Alzheimers Dis. 2016;50(1):271-82. doi: 10.3233/JAD-150563.

6.

Theory of Mind and social reserve: Alternative hypothesis of progressive Theory of Mind decay during different stages of Alzheimer's disease.

Fliss R, Le Gall D, Etcharry-Bouyx F, Chauviré V, Desgranges B, Allain P.

Soc Neurosci. 2016;11(4):409-23. doi: 10.1080/17470919.2015.1101014. Epub 2015 Oct 21.

PMID:
26490734
7.

Greater than the Sum of Its Parts: δ can be Constructed from Item Level Data.

Royall DR, Palmer RF, Matsuoka T, Kato Y, Taniguchi S, Ogawa M, Fujimoto H, Okamura A, Shibata K, Nakamura K, Nakaaki S, Koumi H, Mimura M, Fukui K, Narumoto J.

J Alzheimers Dis. 2016;49(2):571-9. doi: 10.3233/JAD-150250.

PMID:
26444760
8.

Enhancing prospective memory in mild cognitive impairment: The role of enactment.

Pereira A, de Mendonça A, Silva D, Guerreiro M, Freeman J, Ellis J.

J Clin Exp Neuropsychol. 2015;37(8):863-77. doi: 10.1080/13803395.2015.1072499. Epub 2015 Aug 19.

PMID:
26313515
9.

The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.

Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, Kramer JH, van der Vlies AE, La Joie R, Rosen HJ, van der Flier WM, Grinberg LT, Rozemuller AJ, Huang EJ, van Berckel BN, Miller BL, Barkhof F, Jagust WJ, Scheltens P, Seeley WW, Rabinovici GD.

Brain. 2015 Sep;138(Pt 9):2732-49. doi: 10.1093/brain/awv191. Epub 2015 Jul 2.

10.

Scaling Cognitive Domains of the Montreal Cognitive Assessment: An Analysis Using the Partial Credit Model.

Freitas S, Prieto G, Simões MR, Santana I.

Arch Clin Neuropsychol. 2015 Aug;30(5):435-47. doi: 10.1093/arclin/acv027. Epub 2015 May 4.

PMID:
25944337
11.

Short-Term Practice Effects and Brain Hypometabolism: Preliminary Data from an FDG PET Study.

Duff K, Horn KP, Foster NL, Hoffman JM.

Arch Clin Neuropsychol. 2015 May;30(3):264-70. doi: 10.1093/arclin/acv018.

12.

Greater than the sum of its parts: δ Improves upon a battery's diagnostic performance.

Royall DR, Matsuoka T, Palmer RF, Kato Y, Taniguchi S, Ogawa M, Fujimoto H, Okamura A, Shibata K, Nakamura K, Nakaaki S, Koumi H, Mimura M, Fukui K, Narumoto J.

Neuropsychology. 2015 Sep;29(5):683-92. doi: 10.1037/neu0000153. Epub 2015 Feb 9.

PMID:
25664465
13.

Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.

Wagshal D, Sankaranarayanan S, Guss V, Hall T, Berisha F, Lobach I, Karydas A, Voltarelli L, Scherling C, Heuer H, Tartaglia MC, Miller Z, Coppola G, Ahlijanian M, Soares H, Kramer JH, Rabinovici GD, Rosen HJ, Miller BL, Meredith J, Boxer AL.

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):244-50. doi: 10.1136/jnnp-2014-308004. Epub 2014 Jun 4.

14.

It is unclear if adjusting cortical thickness for changes in gray/white matter intensity ratio improves discrimination between normal aging, MCI, and AD.

Bauer CM, Cabral HJ, Killiany RJ; Alzheimer’s Disease Neuroimaging Initiative..

Brain Imaging Behav. 2014 Mar;8(1):133-40. doi: 10.1007/s11682-013-9268-6.

15.

Visuospatial function in early Alzheimer's disease--the use of the Visual Object and Space Perception (VOSP) battery.

Quental NB, Brucki SM, Bueno OF.

PLoS One. 2013 Jul 16;8(7):e68398. doi: 10.1371/journal.pone.0068398. Print 2013.

16.

Testing visual perception in dementia with Lewy bodies and Alzheimer disease.

Wood JS, Firbank MJ, Mosimann UP, Watson R, Barber R, Blamire AM, O'Brien JT.

Am J Geriatr Psychiatry. 2013 Jun;21(6):501-8. doi: 10.1016/j.jagp.2012.11.015. Epub 2013 Jan 11.

PMID:
23567415
17.

Posterior cortical atrophy: a case study of Benson's syndrome that initially presented as anxiety disorder.

Everhart DE, Highsmith JM, Davis CE.

Appl Neuropsychol Adult. 2012;19(3):229-36. doi: 10.1080/09084282.2012.686791. Epub 2012 May 31.

PMID:
23373609
18.

Amyloid deposition, hypometabolism, and longitudinal cognitive decline.

Landau SM, Mintun MA, Joshi AD, Koeppe RA, Petersen RC, Aisen PS, Weiner MW, Jagust WJ; Alzheimer's Disease Neuroimaging Initiative..

Ann Neurol. 2012 Oct;72(4):578-86. doi: 10.1002/ana.23650.

19.

Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.

Lee YM, Park JM, Lee BD, Moon E, Chung YI, Kang CJ.

Dement Geriatr Cogn Disord. 2012;33(4):240-4. doi: 10.1159/000339159. Epub 2012 Jun 11.

PMID:
22738930
20.

Validity of a brief computerized cognitive screening test in dementia.

Hammers D, Spurgeon E, Ryan K, Persad C, Barbas N, Heidebrink J, Darby D, Giordani B.

J Geriatr Psychiatry Neurol. 2012 Jun;25(2):89-99. doi: 10.1177/0891988712447894.

PMID:
22689701

Supplemental Content

Loading ...
Support Center